U.S. Renewable Energy Stock News

NYSE:AHRT
NYSE:AHRTREITs

Undervalued Small Caps With Insider Buying To Consider In May 2026

The United States market has seen a robust performance recently, climbing 1.8% in the last week and 30% over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying small-cap stocks that are perceived as undervalued and have insider buying can provide unique opportunities for investors seeking potential growth.
NYSE:WMB
NYSE:WMBOil and Gas

3 Stocks Estimated To Be Priced Below Intrinsic Value In May 2026

The United States market has shown robust performance, climbing 1.8% in the last week and achieving a 30% increase over the past year, with earnings expected to grow by 16% annually. In this thriving environment, identifying stocks that are priced below their intrinsic value can offer investors opportunities for potential gains while maintaining a focus on fundamental strengths and growth prospects.
NasdaqCM:VUZI
NasdaqCM:VUZIElectronic

Undervalued Penny Stocks To Watch In May 2026

The United States market has shown strong performance recently, with a 1.8% increase over the last week and a notable 30% rise over the past year, alongside forecasts of annual earnings growth of 16%. In such a robust market environment, identifying stocks with solid fundamentals is crucial for investors looking to capitalize on growth opportunities. While the term "penny stocks" may seem outdated, it still refers to smaller or newer companies that can offer significant value when they...
NasdaqGS:JBSS
NasdaqGS:JBSSFood

Undiscovered Gems In The US Market For May 2026

The United States market has shown impressive momentum, rising 1.8% over the last week and climbing 30% in the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying stocks that are not only poised for growth but also remain under the radar can offer unique opportunities for investors seeking to capitalize on emerging potential.
NYSE:ROL
NYSE:ROLCommercial Services

Rollins Weighs Growth Options As Orkin Mosquito Data Highlights Urban Demand

Orkin, a Rollins (NYSE:ROL) brand, released its 2026 Mosquito Cities List, ranking U.S. metro areas based on mosquito activity. Large cities such as Los Angeles, Chicago, and New York feature prominently on the list, pointing to wider geographic mosquito pressure. Orkin is working with the American Red Cross on a national campaign during peak mosquito season focused on awareness and community support. For Rollins, a company focused on residential and commercial pest control services, the...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

MarketAxess Partnership With Moment Tests New Growth In Advisor Channels

MarketAxess Holdings (NasdaqGS:MKTX) announced a new partnership with Moment. The collaboration connects MarketAxess’s institutional fixed income liquidity and pricing to wealth managers and retail advisors via the Moment platform. The deal extends MarketAxess’s reach beyond traditional institutional clients into larger wealth management and registered investment advisor channels. MarketAxess runs an electronic trading platform focused on corporate and other fixed income securities,...
NYSE:CVSA
NYSE:CVSAConsumer Services

Is Covista (CVSA) Offering Value After Recent Share Price Gains?

This article walks through key numbers to help you judge whether Covista is priced attractively or already fully valued, so you can compare the stock against your own expectations. Covista recently closed at US$118.07, with returns of 4.3% over the last week, 0.1% over the past month, 13.0% year to date and 4.7% over the last year. Recent coverage around Covista has focused on its share price performance and how investors are reassessing the stock in light of broader sector moves. This...
NYSE:RCUS
NYSE:RCUSBiotechs

Is It Too Late To Consider Arcus Biosciences (RCUS) After Its 221% One Year Surge?

If you are wondering whether Arcus Biosciences is reasonably priced or getting ahead of itself, the current share price invites a closer look at what investors may actually be paying for. The stock last closed at US$26.06, with returns of 5.1% over the past 7 days, 13.5% over 30 days, 11.9% year to date, and 220.9% over the last year, which points to a stock that has already seen significant movement. Recent coverage around Arcus Biosciences has focused on its position in the biotech space...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Is It Time To Reconsider Upstart Holdings (UPST) After Recent Share Price Swings?

If you are wondering whether Upstart Holdings at around US$31.17 is priced for a comeback or still carrying too much risk, the starting point is to understand what the current market value really reflects. The stock has been volatile, with a 5.1% decline over the last 7 days, a 21.9% gain over the last 30 days, a 32.0% decline year to date, and a 39.4% decline over the last year. The 3-year return sits at 121.2%, and the 5-year return at a 65.1% decline. Recent coverage around Upstart often...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

ARK Invest’s NTLA Buy Puts Dilution And CRISPR Progress In Focus

ARK Invest recently acquired over 3 million Intellia Therapeutics shares, worth more than US$43 million. The purchase reflects increased institutional interest in Intellia Therapeutics, which trades under ticker NasdaqGM:NTLA. This transaction follows earlier coverage that focused on Intellia's clinical programs, regulatory updates, and financial position. Intellia Therapeutics focuses on CRISPR/Cas9-based therapeutics, an area that many investors watch closely as gene editing moves from...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

A Look At Soleno Therapeutics (SLNO) Valuation After Recent Share Momentum And VYKAT XR Launch Progress

Soleno Therapeutics stock overview Soleno Therapeutics (SLNO) has drawn investor attention after recent share performance, with the stock showing a one-month return of 34.01% and a three-month return of 25.64%. See our latest analysis for Soleno Therapeutics. That recent momentum sits against a mixed longer record, with a 34.01% 1 month share price return and 25.64% 3 month share price return contrasting with a 28.21% 1 year total shareholder return decline but a very large 3 year total...
NYSE:ITGR
NYSE:ITGRMedical Equipment

Integer Holdings Review Tests Shareholder Value As Profitability Improves

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...